Skip to content
Unknown statusN/A

Auditory MMN EEG in TRD in Response to Ketamine

NCT05464264 · Unity Health Toronto

Closed to entry
Status
Not accepting participants
Not applicable
Phase
30
Target enrolment
1
Study sites
Outside the US

What it is testing

Summary

To develop and test a neurocomputational model of ketamine treatment response predictions in TRD.

Summary as written by the trial’s own sponsor and published on ClinicalTrials.gov API v2. It is the sponsor’s description, reproduced unedited, not an assessment by this site.

What counts as success

Primary outcome measures

  • Clinical remission

    Measured over 4 weeks following the baseline visit

A trial succeeds or fails on its primary outcome, declared in advance. Everything else it reports is secondary by definition.

Who can take part

Eligibility, as published

18 Years to 65 Years
Ages
All
Sex
Not accepted
Healthy volunteers
Inclusion Criteria: 1.18 to 65 years of age 2. Meeting Diagnostic and Statistical Manual for Mental Disorders (DSM-5) criteria for MDD and in a Major Depressive Episode and ≥10 on the Montgomery-Asberg Depression Rating Scale (MADRS). 3\. Competent to consent-based on their ability to provide a spontaneous narrative description of the key elements of the study. 4\. Failure of at least two trials of antidepressant therapy during the current episode (treatment-resistant depression) and receiving ketamine treatment clinically as administered by their clinician 5. Staying on stable dosages of any concomitant psychotropic medications. Exclusion Criteria: 1. History of bipolar disorder or psychosis 2. Current substance use or history of substance use during the past year (excluding nicotine and caffeine use disorder) 3. Concomitant major and unstable medical or neurologic illness or a history of seizures. 4. Non-English-speaking individuals.

Where

1 study site

FacilityCityRegionCountry
St. Michael's HospitalTorontoOntarioCanada

On the registry

Contact the trial directly

This site does not enrol anyone and is not involved in this trial. To ask about taking part, use the sponsor’s own contact details on the official registry record, which is also where the most current version of everything above lives.

Before you do, the preparation checklist lists what a site will ask you on a first call and what is worth asking them. It is free and collects nothing.

NCT05464264 on ClinicalTrials.gov →

Last updated in the registry 2023-11-29. Registry records change; this page reflects the data build of 2026-08-25.

Related

Where this trial sits